356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease - Ellen Bradley; D Parker Kelley; Martin Picard; Balazs Szigeti; Kimberly Sakai; Gisele Fernandes; Jill Ostrem; Caroline Tanner; Patrick Finley; Connie Ludwig; Katiah Llerena; Zach Busby; et al. (Biological Psychiatry, 2026)